Amneal Pharmaceuticals (AMRX) Invested Capital (2017 - 2026)
Amneal Pharmaceuticals (AMRX) posted quarterly Invested Capital of $6.2 million for Q1 2026, down 80.5% year-over-year from $31.8 million in Q1 2025, and down 89.38% quarter-over-quarter from $58.4 million in Q4 2025.
Amneal Pharmaceuticals (AMRX) Invested Capital (2017 - 2026) Analysis & Trends
Amneal Pharmaceuticals' Invested Capital history runs 10 years deep, the most recent figure standing at $6.2 million for Q1 2026.
- In Q1 2026, Invested Capital fell 80.5% year-over-year to $6.2 million; the TTM figure through Mar 2026 stood at $361.8 million (down 33.22% YoY), while the FY2025 annual figure was $58.4 million, down 2.88% from the prior year.
- Invested Capital for Q1 2026 stood at $6.2 million, down from $58.4 million in the prior quarter.
- The five-year high for Invested Capital was $290.0 million in Q2 2025, with the low at $6.2 million in Q1 2026.
- The 5-year median for Invested Capital is $33.7 million (2024), against an average of $75.5 million.
- The sharpest annual moves came in 2024 and 2025: Invested Capital surged 640.52% in 2024, then slumped 96.79% in 2025.
- Amneal Pharmaceuticals' Invested Capital stood at $64.3 million in 2022, then declined by 5.02% to $61.0 million in 2023, then dropped by 1.53% to $60.1 million in 2024, then decreased by 2.88% to $58.4 million in 2025, then sank by 89.38% to $6.2 million in 2026.
- Business Quant data shows AMRX's Invested Capital at $6.2 million in Q1 2026, $58.4 million in Q4 2025, and $7.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | 9.90 Bn |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 4.50 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 3.74 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 1.74 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 73.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 630.00 Mn |
| 10 | Amneal Pharmaceuticals | 5.72 Bn | 5.59 Bn | 334.51 Mn | 100.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 100.00 Mn |
| Mar 31, 2026 | 6.20 Mn |
| Dec 31, 2025 | 58.37 Mn |
| Sep 30, 2025 | 7.20 Mn |
| Jun 30, 2025 | 290.00 Mn |
| Mar 31, 2025 | 31.79 Mn |
| Dec 31, 2024 | 60.10 Mn |
| Sep 30, 2024 | 224.69 Mn |
| Jun 30, 2024 | 225.16 Mn |
| Mar 31, 2024 | 33.66 Mn |
| Dec 31, 2023 | 61.03 Mn |
| Sep 30, 2023 | 30.53 Mn |
| Jun 30, 2023 | 30.41 Mn |
| Mar 31, 2023 | 29.97 Mn |
| Dec 31, 2022 | 64.26 Mn |
| Sep 30, 2022 | 29.94 Mn |
| Jun 30, 2022 | 85.00 Mn |
| Mar 31, 2022 | 15.96 Mn |
| Dec 31, 2021 | 63.35 Mn |
| Sep 30, 2021 | 30.47 Mn |